Hepatology

Viral Hepatitis

Questions discussed in this category

How would you manage a patient with well-controlled HIV on Biktarvy, who is interested in switching to injectable HAART but also has a history of a prior Hepatitis B Infection?

2 Answers available

How do you approach the use of the quantification of HBsAg titers in chronic hepatitis B infection who are eAg negative with viral suppression on treatment?

1 Answer available

In patients with hepatitis B and co-infection with hepatitis D, given their increased risk of development of HCC, how do you approach screening for this?

What other management considerations are on your mind in such patients?

1 Answer available

When would you consider quantification of hepatitis B surface antigen as part of the treatment decision making process?

2 Answers available

Pending final results, but in what scenario would you select bepirovirsen as opposed to established therapy for hepatitis B patients (ex: TAF or TDF)?

Is an attempt for a functional cure the goal for all patients?

1 Answer available

Should an individual who received the purified protein Hepatitis B vaccine in 1985 receive a booster or have antibody titers checked?

1 Answer available

How do you approach the surveillance and serologic evaluation of a patient in whom you suspect has a hepatitis B pre-core mutant?

What findings would suggest to you that a patient has a pre-core mutant?

1 Answer available

How do you explain the additional risks that a transplant recipient may carry by pursuing a hepatitis C positive organ if they are negative?

1 Answer available

What clinical scenario do you consider screening for hepatitis delta?

1 Answer available

In what scenario do you screen patients with hepatitis B for hepatitis D co-infection?

1 Answer available

What kind of monitoring do you choose in patients at risk for reactivation of hepatitis B who are on immunosuppression?

1 Answer available

In what scenarios do you defer treatment of a patient's hepatitis C if they are undergoing liver transplant evaluation?

1 Answer available

What role is there for the assessment of hepatitis B virus genotype as it pertains to pharmacologic therapy and HCC screening?

1 Answer available

All things being equal, what patient factors are you looking at in the selection of TAF or TDF in the management of hepatitis B?

1 Answer available

When would you consider quantification of hepatitis B surface antigen as part of the treatment decision making process?

1 Answer available

Papers discussed in this category

The New England journal of medicine, 1987-03-05

Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV.

Hepatology (Baltimore, Md.), 2018 Apr

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020 Dec 31

Global Burden of Hepatitis B Infection in People Living With Human Immunodeficiency Virus: A Systematic Review and Meta-analysis.

Journal of viral hepatitis, 2019 Dec 22

Prevalence and burden of HBV co-infection among people living with HIV: A global systematic review and meta-analysis.

Topics in antiviral medicine, 2023 Mar 31

Chronic hepatitis B and HIV coinfection.

Journal of acquired immune deficiency syndromes (1999), 2023 Oct 01

Brief Report: Hepatitis B Infection or Reactivation After Switch to 2-Drug Antiretroviral Therapy: A Case Series, Literature Review, and Management Discussion.

Hepatology

Viral Hepatitis

Questions discussed in this category

Papers discussed in this category

Related Topics in Hepatology